Comparative metabolism of aflatoxin B1 in mouse, rat and human primary hepatocytes using HPLC-MS/MS

Aflatoxin B-1 (AFB(1)) is a highly hepatotoxic and carcinogenic mycotoxin produced by Aspergillus species. The compound is mainly metabolized in the liver and its metabolism varies between species. The present study quantified relevant AFB(1)- metabolites formed by mouse, rat, and human primary hepatocytes after treatment with 1 mu M and 10 mu M AFB(1). The use of liquid chromatographic separation coupled with tandem mass spectrometric detection enabled the selective and sensitive determination of phase I and phase II metabolites of AFB(1) over incubation times of up to 24 h. The binding of AFB(1) to macromolecules was also considered. The fastest metabolism of AFB(1) was observed in mouse hepatocytes which formed aflatoxin P-1 as a major metabolite and also its glucuronidated form, while AFP(1) occurred only in traces in the other species. Aflatoxin M-1 was formed in all species and was, together with aflatoxin Q(1) and aflatoxicol, the main metabolite in human cells. Effective epoxidation led to high amounts of DNA adducts already 30 min post-treatment, especially in rat hepatocytes. Lower levels of DNA adducts and fast DNA repair were found in mouse hepatocytes. Also, protein adducts arising from reactive intermediates were formed rapidly in all three species. Detoxification via glutathione conjugation and subsequent formation of the N-acetylcysteine derivative appeared to be similar in mice and in rats and strongly differed from human hepatocytes which did not form these metabolites at all. The use of qualitative reference material of a multitude of metabolites and the comparison of hepatocyte metabolism in three species using advanced methods enabled considerations on toxification and detoxification mechanisms of AFB(1). In addition to glutathione conjugation, phase I metabolism is strongly involved in the detoxification of AFB(1).

Automated summary

This study analyzed the metabolites formed by mouse, rat, and human primary hepatocytes after treatment with different concentrations of Aflatoxin B-1 (AFB(1)). The results showed species-specific differences in the metabolism of AFB(1) and provided insights into the toxification and detoxification mechanisms of AFB(1).